Advertisement

Ads Placeholder
Loading...

Aditxt, Inc.

ADTXNASDAQ
Healthcare
Biotechnology
$0.79
$-0.11(-11.72%)
U.S. Market opens in 18h 28m

Aditxt, Inc. Fundamental Analysis

Aditxt, Inc. (ADTX) shows weak financial fundamentals with a PE ratio of -0.00, profit margin of -13490.28%, and ROE of -30.61%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.

Key Strengths

Cash Position1077954.95%
PEG Ratio-0.00

Areas of Concern

ROE-30.61%
Operating Margin-6125.42%
Current Ratio0.31
We analyze ADTX's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of -1397529.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
-1397529.8/100

We analyze ADTX's fundamental strength across five key dimensions:

Efficiency Score

Weak

ADTX struggles to generate sufficient returns from assets.

ROA > 10%
-2.61%

Valuation Score

Excellent

ADTX trades at attractive valuation levels.

PE < 25
-0.00
PEG Ratio < 2
-0.00

Growth Score

Weak

ADTX faces weak or negative growth trends.

Revenue Growth > 5%
N/A
EPS Growth > 10%
N/A

Financial Health Score

Moderate

ADTX shows balanced financial health with some risks.

Debt/Equity < 1
0.54
Current Ratio > 1
0.31

Profitability Score

Weak

ADTX struggles to sustain strong margins.

ROE > 15%
-3061.44%
Net Margin ≥ 15%
-13490.28%
Positive Free Cash Flow
No

Key Financial Metrics

Is ADTX Expensive or Cheap?

P/E Ratio

ADTX trades at -0.00 times earnings. This suggests potential undervaluation.

-0.00

PEG Ratio

When adjusting for growth, ADTX's PEG of -0.00 indicates potential undervaluation.

-0.00

Price to Book

The market values Aditxt, Inc. at 0.00 times its book value. This may indicate undervaluation.

0.00

EV/EBITDA

Enterprise value stands at -0.01 times EBITDA. This is generally considered low.

-0.01

How Well Does ADTX Make Money?

Net Profit Margin

For every $100 in sales, Aditxt, Inc. keeps $-13490.28 as profit after all expenses.

-13490.28%

Operating Margin

Core operations generate -6125.42 in profit for every $100 in revenue, before interest and taxes.

-6125.42%

ROE

Management delivers $-30.61 in profit for every $100 of shareholder equity.

-30.61%

ROA

Aditxt, Inc. generates $-2.61 in profit for every $100 in assets, demonstrating efficient asset deployment.

-2.61%

Following the Money - Real Cash Generation

Operating Cash Flow

Aditxt, Inc. generates limited operating cash flow of $-184.92M, signaling weaker underlying cash strength.

$-184.92M

Free Cash Flow

Aditxt, Inc. generates weak or negative free cash flow of $-185.02M, restricting financial flexibility.

$-185.02M

FCF Per Share

Each share generates $-68804.98 in free cash annually.

$-68804.98

FCF Yield

ADTX converts -12032819.29% of its market value into free cash.

-12032819.29%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-0.00

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.00

vs 25 benchmark

P/B Ratio

Price to book value ratio

0.00

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.001

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.54

vs 25 benchmark

Current Ratio

Current assets to current liabilities

0.31

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-30.61

vs 25 benchmark

ROA

Return on assets percentage

-2.61

vs 25 benchmark

ROCE

Return on capital employed

-4.55

vs 25 benchmark

How ADTX Stacks Against Its Sector Peers

MetricADTX ValueSector AveragePerformance
P/E Ratio-0.0028.45 Better (Cheaper)
ROE-3061.44%763.00% Weak
Net Margin-1349028.20%-45265.00% (disorted) Weak
Debt/Equity0.540.34 Weak (High Leverage)
Current Ratio0.312795.60 Weak Liquidity
ROA-260.96%-16588.00% (disorted) Weak

ADTX outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Aditxt, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

N/A

Industry Style: Defensive, Growth, Innovation

EPS CAGR

N/A

Industry Style: Defensive, Growth, Innovation

FCF CAGR

N/A

Industry Style: Defensive, Growth, Innovation

Fundamental Analysis FAQ